Goal & Research Areas

The Translational core will provide advice across all aspects of therapeutic development from target validation to commercialization; the core will also connect researchers to the appropriate advisors and facilities as appropriate to their projects.

Hot Topic

Jeffrey Glenn receives $69 million to start antiviral drug-discovery center at Stanford

The National Institute for Allergy and Infectious Diseases has awarded Jeffrey Glenn, MD, PhD, professor of hepatology and gastroenterology and of microbiology and immunology, $69 million...

Single drug injection wards off COVID-19 hospitalizations, in Stanford Medicine-led trial

A single dose of lambda-interferon reduced hospitalization among COVID-19 outpatients in a late-stage study spearheaded by a Stanford Medicine virologist.

Antiviral Program for Pandemics

The Antiviral Program for Pandemics (APP) aims to develop safe and effective antivirals to combat SARS-CoV-2, the virus that causes COVID-19, as well as to build sustainable platforms for targeted drug discovery and development of a robust pipeline of antivirals against viruses with pandemic potential.

ViRx Home Page

Translation Accelerator Core

Goal & Research Areas

Core Leader & Team

Kevin Grimes

Mark Smith

Jianwei Che

Nathanael S. Gray

Chaitan Khosla

Hot Topic

Jeffrey Glenn receives $69 million to start antiviral drug-discovery center at Stanford

Single drug injection wards off COVID-19 hospitalizations, in Stanford Medicine-led trial

Antiviral Program for Pandemics